AMUNDI ASSET MANAGEMENT US, INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMUNDI ASSET MANAGEMENT US, INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$4,682,000
+5.9%
42,174
+13.3%
0.00%0.0%
Q4 2020$4,421,000
+55.9%
37,233
+14.5%
0.00%
+33.3%
Q3 2020$2,835,000
+23.5%
32,504
+26.8%
0.00%0.0%
Q2 2020$2,296,000
-2.2%
25,643
+8.8%
0.00%
-25.0%
Q1 2020$2,347,000
-39.6%
23,559
-30.3%
0.00%
-20.0%
Q4 2019$3,883,000
+25.7%
33,797
+38.0%
0.01%0.0%
Q3 2019$3,090,000
+377.6%
24,499
+231.5%
0.01%
+400.0%
Q1 2019$647,000
-12.4%
7,3910.0%0.00%0.0%
Q4 2018$739,000
+234.4%
7,391
+283.9%
0.00%
Q3 2018$221,000
-95.9%
1,925
-98.5%
0.00%
-100.0%
Q4 2012$5,378,000131,6800.02%
Other shareholders
HAEMONETICS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders